P. Lapidari

Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatigue

S. Michiels, F. André, S. Dauchy, 2021, Breast Cancer Research and Treatment.

Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancer

F. André, C. Coutant, O. Trédan, 2021, Breast.

Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience

P. Lapidari, A. Bernardo, C. Teragni, 2019, Therapeutic advances in medical oncology.

Palbociclib in metastatic breast cancer: current evidence and real-life data

P. Lapidari, E. Quaquarini, R. Palumbo, 2019, Drugs in context.

Factors associated with enrolment in clinical trials among women with early-stage breast cancer

A. Di Meglio, E. Martin, B. Pistilli, 2022, ESMO open.

Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis

N. Lin, S. Michiels, P. Ganz, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer

C. Coutant, O. Trédan, A. Di Meglio, 2022, Cancer.

Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic review.

A. Di Meglio, I. Vaz-Luis, P. Lapidari, 2020, Critical reviews in oncology/hematology.